序号 |
标题 |
次数 |
作者 |
发布时间 |
75916 |
cas:1116086-09-9,Fmoc-Phe -Lys(Trt)-PAB-PNP, ADC试剂 |
74 |
kx |
2024-12-19 |
75917 |
N3-C5-NHS ester CAS:866363-70-4 |
96 |
zyl |
2024-12-19 |
75918 |
CAS号:2055024-54-7,化合物:Boc-PEG4-Val-Cit-PAB-OH,叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
85 |
WYQ |
2024-12-19 |
75919 |
DOTA-DPhe1-Tyr3-octreotide DOTA-DPhe 1-Tyr 3-奥曲肽 |
90 |
h |
2024-12-19 |
75920 |
CAS号:870487-10-8,化合物:Boc-Val-Cit-PAB-PNP |
86 |
WYQ |
2024-12-19 |
75921 |
DOTA-PESIN 金属螯合剂DOTA偶联多肽 |
93 |
h |
2024-12-19 |
75922 |
(Ac)Phe-Lys(Alloc)-PABC-PNP, ADC试剂 |
79 |
kx |
2024-12-19 |
75923 |
Mal-PEG8-Val-Cit-PAB-PNP,C47H67N9O19 |
142 |
WYQ |
2024-12-19 |
75924 |
DBCO-PEG3-Val-Cit-PAB-PNP,ADC定制 |
87 |
wyh |
2024-12-19 |
75925 |
[d-Phe7]-α-MSH3-10 |
100 |
h |
2024-12-19 |
75926 |
cas:863971-53-3,Fmoc-Val-Cit-PAB-PNP, ADC试剂 |
106 |
kx |
2024-12-19 |
75927 |
CAS: 2055041-37-5, Mal-PEG1-Val-Cit-PAB-OH(有时也被称为Mal-PEG1-Val-Cit-PABC-OH) |
89 |
WYQ |
2024-12-19 |
75928 |
Mal-L-PA-NH-Boc CAS:1491152-23-8 |
83 |
zyl |
2024-12-19 |
75929 |
cas:2504147-53-7 ,Mal-amido-PEG2-Val-Cit-PAB-OH,ADC定制 |
92 |
wyh |
2024-12-19 |
75930 |
Mal-PEG1-Val-Cit-OH,马来酰亚胺-一聚乙二醇-VAL-CIT-羟基 |
90 |
WYQ |
2024-12-19 |
75931 |
cas:1342820-51-2,SGD-1910, ADC试剂 |
113 |
kx |
2024-12-19 |
75932 |
Ald-Ph-amido-PEG2-C2-Pfp ester CAS:2101206-60-2 |
96 |
zyl |
2024-12-19 |
75933 |
cas:1228105-52-9,DM4-SMCC, ADC试剂 |
104 |
kx |
2024-12-19 |
75934 |
马来酰亚胺-八聚乙二醇-缬氨酸-瓜氨酸-PAB-PNP酯,ADC定制 |
95 |
wyh |
2024-12-19 |
75935 |
cas:863971-56-6,Val-Cit-PAB-MMAF, ADC试剂 |
71 |
kx |
2024-12-19 |
75936 |
SPDMB CAS:2101206-29-3合成方法 |
90 |
zyl |
2024-12-19 |
75937 |
cas:2055041-39-7,Mal-PEG4-Val-Cit-PAB-OH,ADC定制 |
90 |
wyh |
2024-12-19 |
75938 |
cas:1347750-81-5,Mal-NH-PEG2-CH2CH2COOPFP ester, ADC试剂 |
81 |
kx |
2024-12-19 |
75939 |
金属螯合剂DOTA偶联α-MSH八肽类似物 |
67 |
h |
2024-12-19 |
75940 |
cas:1286715-33-0,2,5-Dioxopyrrolidin-1-yl 4-methyl-4-((2-methyl-5-oxo-5-(2-(trimethylsilyl)ethoxy)pentan-2-yl)disulfanyl)pentanoate |
108 |
kx |
2024-12-19 |
75941 |
DOTA-conjugated multivalent cyclic-RGD DOTA-共轭多价环RGD肽树枝状大分子 |
78 |
h |
2024-12-19 |
75942 |
Azidoethyl-SS-ethylazide CAS:352305-38-5 |
84 |
zyl |
2024-12-19 |
75943 |
CAS: 870487-09-5, Boc-Val-Cit-PAB |
84 |
WYQ |
2024-12-19 |
75944 |
cas:2101206-67-9,Ald-Ph-amido-PEG1-C2-Pfp ester, ADC试剂 |
74 |
kx |
2024-12-19 |
75945 |
Ald-Ph-amido-PEG11-NH-Boc CAS:1245813-70-0 |
108 |
zyl |
2024-12-19 |
75946 |
HSA-2-iminothiolane-DOTA HSA-2-亚氨基硫醇-DOTA |
93 |
h |
2024-12-19 |
75947 |
cas:1222787-24-7,2,5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-oxobutanoate |
208 |
kx |
2024-12-19 |
75948 |
Tr-PEG5-OH CAS:141282-24-8物理化学性质 |
100 |
zyl |
2024-12-19 |
75949 |
CAS: 870487-08-4,Boc-Val-Cit,(S)-2-((S)-2-((叔丁氧基羰基)氨基)-3-甲基丁酰胺基)-5-脲基戊酸 |
98 |
WYQ |
2024-12-19 |
75950 |
DOTA-8-Aoc-BBN[7-14]NH |
109 |
h |
2024-12-19 |
75951 |
Fmoc-PEG3-Val-Cit,N-Fluorenylmethoxycarbonyl-triethylene glycol-Val-Cit |
87 |
WYQ |
2024-12-19 |
75952 |
CAS: 2226472-28-0,DBCO-PEG4-Val-Cit-PAB-PNP |
79 |
WYQ |
2024-12-19 |
75953 |
CAS: 2055024-64-9,Azido-PEG4-Val-Cit-PAB-OH |
89 |
WYQ |
2024-12-19 |
75954 |
CAS: 870487-09-5,Boc-Val-Cit-PAB |
89 |
WYQ |
2024-12-19 |
75955 |
CAS:784105-33-5 Amino-PEG3-C2-acid的介绍 |
75 |
zyl |
2024-12-19 |
75956 |
CAS 863971-53-3:Fmoc-Val-Cit-PAB-PNP |
91 |
WYQ |
2024-12-19 |
75957 |
Ald-Ph-amido-PEG11-C2-NH2 CAS:1337889-01-6 |
74 |
zyl |
2024-12-19 |
75958 |
cas:2003260-13-5 , MA-PEG4-Ala-Ala-PAB-PNP,ADC定制 |
75 |
wyh |
2024-12-19 |
75959 |
DOTA-NCS-6-Ahx-Phe 19-ST[1-19] DOTA偶联ST肽类似物 |
105 |
h |
2024-12-19 |
75960 |
1,4,7,10-四氮杂-n-(1-羧基-3-(4-硝基苯基)丙基)-n,N , N ‴-tris(acetic酸)环十二烷(PA-DOTA) |
73 |
h |
2024-12-19 |